from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2771c/-

LFCtreatmentdescriptionclass of inhibitor

-0.269

Amikacinug/mL Amikacintranslation

-0.720

Cap5-10ug/mL Capreomycintranslation

-1.075

Rox10-50 ug/mL Roxithromycintranslation

-0.494

SM2-5 ug/mL Streptomycintranslation

-0.693

Tet5-10 ug/mL Tetracyclinetranslation

-0.015

Rif0.2-5ug/mL Rifampicintranscription

1.035

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.724

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.602

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.022

CPZ10-50 ug/mL Chlorpromazinerespiration

0.248

Clofazimine10-13 ug/mL Clofaziminerespiration

0.468

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.562

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.950

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.409

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.384

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.292

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.140

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.453

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.696

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.315

KCN5-20 ug/mL Potassium cyaniderespiration

-0.771

NaN30.2-2 mM Sodium aziderespiration

-0.822

Nigericin50 uM Nigericinrespiration

0.661

TRC10-150 ug/mL Triclosanrespiration

0.177

TRZ10-25 ug/mL Thioridazinerespiration

-1.236

Valinomycin0.5-10 uM Valinomycinrespiration

-1.939

ZnSO42 mM ZnSO4respiration

-0.174

menadione6-10 ug/mL Menadionerespiration

0.515

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.167

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.451

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.650

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.042

NRP_1Non-replicating persistence stage 1dosRassociated

-0.517

Amp0.2mg/mL AmpicillincellWall

-0.364

Cephalexin20-100 ug/mL CephalexincellWall

-0.115

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.850

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.524

EMB10-20 ug/mL EthambutolcellWall

-1.085

Eta12-40 ug/mL EthionamidecellWall

-1.087

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.020

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.051

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.126

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.128

BZA0.12 mg/mL BenzamidearomaticAmides

0.067

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.149

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.425

H2O24 mM hydrogen peroxideDNAdamaging

-0.459

Levo10 ug/mL LevofloxacinDNAdamaging

-0.303

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.631

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.538

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.405

UVUV-irradiationDNAdamaging

0.439

ARP41-4 ug/mL Antitubercular compound ARP4?

0.367

Antimycin12.5-50 ug/mL Antimycin A?

0.267

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.128

PA_110-50 ug/mL Antitubercular compound PA-1?

0.924

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.128

PA8240.2-2 ug/mL PA-824?

-0.175

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.159

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.299

Verapamil50 uM Verapamil?

0.733

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.288

methoxatin10-20 ug/mL Methoxatin?